S. 2512 — Introduced in Senate

II 114th CONGRESS 2d Session S. 2512 IN THE SENATE OF THE UNITED STATES February 8, 2016Mr. Franken (for himself, Mr. Nelson, Mr. Isakson, and Mr. Brown) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To expand the tropical disease product priority review voucher program to encourage treatments for Zika virus. 1. Short title This Act may be cited as the Adding Zika Virus to the FDA Priority Review Voucher Program Act. 2. Expanding tropical disease product priority review voucher program to encourage treatments for Zika virus Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended— (1) by redesignating subparagraph (R) as subparagraph (S); and (2) by inserting after subparagraph (Q) the following: (R) Zika virus. .